Cancers ‘change spots’ to avoid immunotherapy

Cancers can make themselves harder for new immunotherapies to see by ‘changing their spots’ — and switching off a key molecule on the surface of cells that is otherwise recognised by treatment. Researchers found that they could test samples from patients with bowel cancer to identify which were most likely to respond to immunotherapy by assessing molecular changes within miniature […]

Read more

Blocking epigenetic Swiss army knife may be a new strategy for treating colorectal cancer

A new study out today in Cancer Cell shows that blocking specific regions of a protein called UHRF1 switches on hundreds of cancer-fighting genes, impairing colorectal cancer cells’ ability to grow and spread throughout the body. “Colorectal cancers are a growing public health problem, particularly in young people who haven’t yet reached the recommended age for regular screening,” said Scott […]

Read more

Small risks may have big impact on breast cancer odds of childhood cancer survivors

St. Jude Children’s Research Hospital researchers have evidence that common genetic variations can help to identify pediatric cancer survivors who are at increased risk for developing breast cancer while relatively young. The findings appear today in the journal Clinical Cancer Research. The research focused on the combined effect of 170 common genetic variations that individually confer a modest increased risk […]

Read more